Erectile dysfunction is the most common complication encountered following radical prostatectomy (complete removal of the prostate) performed for prostate cancer treatment. Even when nerve-sparing techniques are utilized during surgery, temporary or permanent nerve damage may develop, leading patients to lose their erectile capacity completely. In cases of erectile dysfunction after prostate cancer surgery, SVF Stem Cell therapy aims to repair these damages at the cellular level.
Cavernous Nerve Damage and the Effect of Stem Cells
The cavernous nerves, which pass directly adjacent to the prostate and carry erectile signals to the penis, can be damaged due to traction or thermal injury during surgery. This condition leads to penile erectile tissue atrophy and venous leak. When SVF stem cells are injected into the penis:
- Neuro-Regeneration (Nerve Repair): Reinitiates neural transmission by repairing damaged micro nerve sheaths.
- Prevents Atrophy: Prevents tissue loss by restoring the nourishment of ischemic penile tissue.
- Restores Erectile Function: Patients regain natural erectile potency as nerve and vascular structures recover.
SVF therapy applied within the first 6–12 months post-surgery maximizes the chance of treatment success.